Home > Insider Trading > Filing (0001209191-16-133847)

Filing Details

Accession Number:: 0001209191-16-133847
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-07-25 17:06:43
Reporting Period:: 2016-07-25

Filing Date:: 2016-07-25
Accepted Time:: 2016-07-25 17:06:43
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1628738	Audentes Therapeutics Inc.	BOLD	()	DE

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1555953	5Am Partners Iii, Llc	2200 Sand Hill Road, Suite 110 Menlo Park CA 94025		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-07-25	1,387,392	$0.00	1,387,392	No	4	C	Indirect	By 5AM Ventures III, L.P.
Common Stock	Acquisiton	2016-07-25	616,874	$0.00	2,004,266	No	4	C	Indirect	By 5AM Ventures III, L.P.
Common Stock	Acquisiton	2016-07-25	259,524	$0.00	2,263,790	No	4	C	Indirect	By 5AM Ventures III, L.P.
Common Stock	Acquisiton	2016-07-25	35,755	$0.00	35,755	No	4	C	Indirect	By 5AM Co-Investors III, L.P.
Common Stock	Acquisiton	2016-07-25	15,898	$0.00	51,653	No	4	C	Indirect	By 5AM Co-Investors III, L.P.
Common Stock	Acquisiton	2016-07-25	6,688	$0.00	58,341	No	4	C	Indirect	By 5AM Co-Investors III, L.P.
Common Stock	Acquisiton	2016-07-25	68,241	$15.00	2,332,031	No	4	P	Indirect	By 5AM Ventures III, L.P.
Common Stock	Acquisiton	2016-07-25	1,759	$15.00	60,100	No	4	P	Indirect	By 5AM Co-Investors III, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	By 5AM Ventures III, L.P.
No	4	C	Indirect	By 5AM Ventures III, L.P.
No	4	C	Indirect	By 5AM Ventures III, L.P.
No	4	C	Indirect	By 5AM Co-Investors III, L.P.
No	4	C	Indirect	By 5AM Co-Investors III, L.P.
No	4	C	Indirect	By 5AM Co-Investors III, L.P.
No	4	P	Indirect	By 5AM Ventures III, L.P.
No	4	P	Indirect	By 5AM Co-Investors III, L.P.

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Preferred Stock	Disposition	2016-07-25	1,387,392	$0.00	1,387,392	$0.00
Common Stock	Series B Preferred Stock	Disposition	2016-07-25	616,874	$0.00	616,874	$0.00
Common Stock	Series C Preferred Stock	Disposition	2016-07-25	259,524	$0.00	259,524	$0.00
Common Stock	Series A Preferred Stock	Disposition	2016-07-25	35,755	$0.00	35,755	$0.00
Common Stock	Series B Preferred Stock	Disposition	2016-07-25	15,898	$0.00	15,898	$0.00
Common Stock	Series C Preferred Stock	Disposition	2016-07-25	6,688	$0.00	6,688	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect

Footnotes

Each share of the issuer's Series A Preferred Stock automatically converted into 1 share of the issuer's Common Stock on July 25, 2016 in connection with the closing of the issuer's sale of its Common Stock in its firm commitment initial public offering (the "IPO") pursuant to a registration statement on Form S-1 (File No. 333-208842) under the Securities Act of 1933, as amended (the "Registration Statement"), and had no expiration date.
5AM Partners III, LLC is the general partner of 5AM Ventures III, L.P. and 5AM Co-Investors III, L.P. Dr. John Diekman, Andrew Schwab and Dr. Scott Rocklage are the managing members of 5AM Partners III, LLC. 5AM Partners III, LLC may be deemed to have sole voting and investment power over the shares beneficially owned by 5AM Ventures III, L.P. and 5AM Co-Investors III, L.P. Dr. Diekman, Mr. Schwab and Dr. Rocklage may be deemed to have shared voting and investment power over the shares beneficially owned by 5AM Ventures III, L.P. and 5AM Co-Investors III, L.P. Each of 5AM Partners III, LLC, Dr. Diekman, Mr. Schwab and Dr. Rocklage disclaim beneficial ownership of such shares, except to the extent of its or his pecuniary interest therein.
Each share of the issuer's Series B Preferred Stock automatically converted into 1 share of the issuer's Common Stock on July 25, 2016 in connection with the closing of the issuer's sale of its Common Stock in its IPO pursuant to the Registration Statement, and had no expiration date.
Each share of the issuer's Series C Preferred Stock automatically converted into 1 share of the issuer's Common Stock on July 25, 2016 in connection with the closing of the issuer's sale of its Common Stock in its IPO pursuant to the Registration Statement, and had no expiration date.